Nicotine

Nicotine
NEUROtiker · Public domain · source
Name	Nicotine
Formula	C10H14N2
Mol weight	162.23 g·mol−1
Appearance	Colorless to pale yellow oily liquid
Melting point	−79 °C
Boiling point	247 °C
Solubility	Miscible with water and organic solvents
Other names	3-(1-Methyl-2-pyrrolidinyl)pyridine

Nicotine is a naturally occurring alkaloid found primarily in members of the Solanaceae family and notable as the principal psychoactive constituent of tobacco. It has a long history of human use in ceremonial, medicinal, and recreational contexts and remains central to debates over addiction, harm reduction, and regulation. Nicotine’s chemical properties, physiological effects, and industrial utility have led to broad scientific, legal, and commercial attention worldwide.

Chemistry and Pharmacology

Nicotine is a bicyclic tertiary amine with a pyridine and a pyrrolidine ring, molecularly characterized by the formula C10H14N2; chemists such as Dmitri Mendeleev and analysts working in the tradition of Justus von Liebig contextualized its place among organic alkaloids. Analytical methods developed by researchers in laboratories affiliated with University of Oxford, Harvard University, and Max Planck Society often employ gas chromatography–mass spectrometry and nuclear magnetic resonance techniques pioneered by teams at Massachusetts Institute of Technology and ETH Zurich. Pharmacologically, nicotine acts as an agonist at neuronal nicotinic acetylcholine receptors, a concept elaborated in studies from National Institutes of Health and academic groups at Johns Hopkins University and Columbia University. Toxicological profiles referenced in reports by World Health Organization and regulatory assessments from Food and Drug Administration inform benchmarks for exposure and risk classification.

History and Sources

Plant sources of nicotine were documented by explorers and naturalists connected to expeditions led by figures such as Christopher Columbus and collectors in the era of Carl Linnaeus, who classified tobacco species. Indigenous practices recorded by chroniclers associated with Hernán Cortés and anthropologists at institutions like Smithsonian Institution described ceremonial uses. Commercial cultivation spread via colonial trade networks influenced by companies such as the British East India Company and agricultural developments in regions governed by Spanish Empire and Portuguese Empire. Botanical sources include Nicotiana tabacum and Nicotiana rustica, while trace occurrences appear in plants cultivated by research programs at Istituto Agrario di San Michele all’Adige and agricultural departments at University of California, Davis.

Production and Manufacturing

Industrial production historically centered in areas dominated by enterprises like Philip Morris International, British American Tobacco, and state firms in countries such as China and India. Modern extraction techniques evolved alongside chemical manufacturing advancements at firms influenced by process engineering from BASF and Dow Chemical Company. Tobacco leaf curing, fermentation protocols developed in agricultural research at Virginia Polytechnic Institute and State University, and solvent extraction processes implemented in factories studied in University of Manchester engineering curricula underpin large-scale nicotine isolation. Synthesis of nicotine and derivatives has been refined in organic chemistry labs modeled after methods taught at Université Paris-Saclay and University of Tokyo.

Mechanism of Action and Pharmacokinetics

Nicotine’s central action involves binding to neuronal nicotinic acetylcholine receptors (nAChRs) distributed in brain regions researched at Salk Institute and Scripps Research. Electrophysiological and imaging studies at Imperial College London and Karolinska Institutet map receptor subtype distributions and downstream dopaminergic modulation involving pathways described in work by neuroscientists affiliated with MIT and Yale University. Absorption kinetics differ by route—smoking, vaping, transdermal patches developed by teams at Johnson & Johnson and GlaxoSmithKline, and oral formulations studied at University of Cambridge—with hepatic metabolism mediated by cytochrome P450 enzymes characterized in research from University of California, San Francisco. Distribution and elimination parameters reported in clinical pharmacology trials overseen by institutions such as National Institute on Drug Abuse inform dosing and toxicity thresholds.

Health Effects and Toxicity

Epidemiological and clinical evidence compiled by World Health Organization, Centers for Disease Control and Prevention, and public health units at London School of Hygiene & Tropical Medicine link nicotine exposure to dependence phenomena evaluated in cohort studies from University College London and University of Melbourne. Cardiorespiratory, developmental, and neurobehavioral outcomes studied in research centers like Karolinska Institutet and McGill University demonstrate risk gradients associated with dosage and developmental timing. Acute toxicity profiles leading to poisoning cases are documented in poison control data aggregated by American Association of Poison Control Centers and clinical toxicology units at Mayo Clinic. Long-term disease associations have been disentangled in population studies conducted by University of Washington and Johns Hopkins Bloomberg School of Public Health.

Uses and Applications

Applications include nicotine replacement therapies developed through pharmaceutical research at Pfizer and GlaxoSmithKline and harm-reduction products commercialized by firms such as Imperial Brands and startups incubated in technology clusters like Silicon Valley. Agricultural uses historically involved biopesticide research at Rothamsted Research and plant breeding programs at International Tobacco Research Institute. In basic and translational neuroscience, nicotine and analogs are tools in receptor pharmacology labs at National Institutes of Health and universities including Stanford University and Princeton University. Forensic and analytical applications are supported by method development in laboratories at Royal Society of Chemistry-affiliated groups.

Regulation and Public Health Policy

Regulatory frameworks addressing production, marketing, and clinical use involve agencies such as Food and Drug Administration, European Medicines Agency, and public health institutions like World Health Organization. Legal measures, taxation policies, and advertising restrictions have been enacted in jurisdictions influenced by rulings from courts such as Supreme Court of the United States and legislative bodies in European Union member states. International trade and control have engaged organizations including World Trade Organization and public health advocates from Campaign for Tobacco-Free Kids and research consortia at Global Tobacco and Nicotine Research Center to shape policy interventions and harm-reduction strategies.

Category:Alkaloids